Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2017-09-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526445.68948.be |
id |
doaj-d155bab70f66419492c74b2b3d85dac3 |
---|---|
record_format |
Article |
spelling |
doaj-d155bab70f66419492c74b2b3d85dac32020-11-25T00:55:14ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742017-09-0159S19319410.1097/01.GOX.0000526445.68948.be201709001-00288Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy StudiesZ. Paul Lorenc, MD, FACS0Lenox Hill hospital, New York, NYhttp://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526445.68948.be |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Z. Paul Lorenc, MD, FACS |
spellingShingle |
Z. Paul Lorenc, MD, FACS Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies Plastic and Reconstructive Surgery, Global Open |
author_facet |
Z. Paul Lorenc, MD, FACS |
author_sort |
Z. Paul Lorenc, MD, FACS |
title |
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies |
title_short |
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies |
title_full |
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies |
title_fullStr |
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies |
title_full_unstemmed |
Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies |
title_sort |
abstract: dwp-450, purified botulinum toxin type a, for the treatment of moderate-to-severe glabellar lines in adult subjects: results from two randomized, double-blind, placebo-controlled, single dose phase iii safety and efficacy studies |
publisher |
Wolters Kluwer |
series |
Plastic and Reconstructive Surgery, Global Open |
issn |
2169-7574 |
publishDate |
2017-09-01 |
url |
http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000526445.68948.be |
work_keys_str_mv |
AT zpaullorencmdfacs abstractdwp450purifiedbotulinumtoxintypeaforthetreatmentofmoderatetosevereglabellarlinesinadultsubjectsresultsfromtworandomizeddoubleblindplacebocontrolledsingledosephaseiiisafetyandefficacystudies |
_version_ |
1725231194596966400 |